Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2019 02:00 ET | Source: Arvelle Therapeutics

Publication dans The Lancet Neurology des résultats d'une étude randomisée évaluant l'innocuité et l'efficacité du cénobamate chez les patients atteints d'épilepsie focale non contrôlée

ZOUG, Suisse, 18 nov. 2019 (GLOBE NEWSWIRE) -- Arvelle Therapeutics GmbH, société biopharmaceutique émergente spécialisée dans les traitements innovants pour les patients atteints de troubles du...
November 15, 2019 02:00 ET | Source: Arvelle Therapeutics

Arvelle to Present at Jefferies 2019 London Healthcare Conference

Arvelle to Present at Jefferies 2019 London Healthcare Conference Zug, Switzerland, November 15, 2019 - Arvelle Therapeutics GmbH (“Arvelle”), an emerging biopharmaceutical company focused on...
November 14, 2019 02:00 ET | Source: Arvelle Therapeutics

Results of Randomized Study Evaluating the Safety and Efficacy of Cenobamate in Patients with Uncontrolled Focal-Onset Epilepsy Published in The Lancet Neurology

ZUG, Switzerland, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Arvelle Therapeutics GmbH, an emerging biopharmaceutical company focused on bringing innovative treatments to patients with CNS disorders, today...
October 31, 2019 02:00 ET | Source: Arvelle Therapeutics

Arvelle Therapeutics Strengthens Management Team with Key New Hires

Arvelle Therapeutics Strengthens Management Team with Key New Hires Appoints Petra Molan as Senior Vice President Commercial and Enrico Dolfini as...